| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.0059 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |